In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis.
PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/43367cf9df764d0c9cb36074fe25178c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:43367cf9df764d0c9cb36074fe25178c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:43367cf9df764d0c9cb36074fe25178c2021-11-18T08:20:57ZIn vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis.1932-620310.1371/journal.pone.0092708https://doaj.org/article/43367cf9df764d0c9cb36074fe25178c2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24786587/?tool=EBIhttps://doaj.org/toc/1932-6203PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a L. amazonensis PSA protein (LaPSA-38S) produced in a L. tarentolae expression system. This was done in individuals cured of cutaneous leishmaniasis due to L. major (CCLm) or L. braziliensis (CCLb) or visceral leishmaniasis due to L. donovani (CVLd) and in healthy individuals. Healthy individuals were subdivided into immune (HHR-Lm and HHR-Li: Healthy High Responders living in an endemic area for L. major or L. infantum infection) or non immune/naive individuals (HLR: Healthy Low Responders), depending on whether they produce high or low levels of IFN-γ in response to Leishmania soluble antigen. Low levels of total IgG antibodies to LaPSA-38S were detected in sera from the studied groups. Interestingly, LaPSA-38S induced specific and significant levels of IFN-γ, granzyme B and IL-10 in CCLm, HHR-Lm and HHR-Li groups, with HHR-Li group producing TNF-α in more. No significant cytokine response was observed in individuals immune to L. braziliensis or L. donovani infection. Phenotypic analysis showed a significant increase in CD4+ T cells producing IFN-γ after LaPSA-38S stimulation, in CCLm. A high positive correlation was observed between the percentage of IFN-γ-producing CD4+ T cells and the released IFN-γ. We showed that the LaPSA-38S protein was able to induce a mixed Th1 and Th2/Treg cytokine response in individuals with immunity to L. major or L. infantum infection indicating that it may be exploited as a vaccine candidate. We also showed, to our knowledge for the first time, the capacity of Leishmania PSA protein to induce granzyme B production in humans with immunity to L. major and L. infantum infection.Rym Chamakh-AyariRachel Bras-GonçalvesNarges Bahi-JaberElodie PetitdidierWafa Markikou-OuniKarim AounJavier MorenoEugenia CarrilloPoonam SalotraHimanshu KaushalNarender Singh NegiJorge ArevaloFrancesca Falconi-AgapitoAngela PrivatMaria CruzJulie PagniezGérard-Marie PapierokFaten Bel Haj RhoumaPilar TorresJean-Loup LemesreMehdi ChenikAmel Meddeb-GarnaouiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 5, p e92708 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Rym Chamakh-Ayari Rachel Bras-Gonçalves Narges Bahi-Jaber Elodie Petitdidier Wafa Markikou-Ouni Karim Aoun Javier Moreno Eugenia Carrillo Poonam Salotra Himanshu Kaushal Narender Singh Negi Jorge Arevalo Francesca Falconi-Agapito Angela Privat Maria Cruz Julie Pagniez Gérard-Marie Papierok Faten Bel Haj Rhouma Pilar Torres Jean-Loup Lemesre Mehdi Chenik Amel Meddeb-Garnaoui In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. |
| description |
PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a L. amazonensis PSA protein (LaPSA-38S) produced in a L. tarentolae expression system. This was done in individuals cured of cutaneous leishmaniasis due to L. major (CCLm) or L. braziliensis (CCLb) or visceral leishmaniasis due to L. donovani (CVLd) and in healthy individuals. Healthy individuals were subdivided into immune (HHR-Lm and HHR-Li: Healthy High Responders living in an endemic area for L. major or L. infantum infection) or non immune/naive individuals (HLR: Healthy Low Responders), depending on whether they produce high or low levels of IFN-γ in response to Leishmania soluble antigen. Low levels of total IgG antibodies to LaPSA-38S were detected in sera from the studied groups. Interestingly, LaPSA-38S induced specific and significant levels of IFN-γ, granzyme B and IL-10 in CCLm, HHR-Lm and HHR-Li groups, with HHR-Li group producing TNF-α in more. No significant cytokine response was observed in individuals immune to L. braziliensis or L. donovani infection. Phenotypic analysis showed a significant increase in CD4+ T cells producing IFN-γ after LaPSA-38S stimulation, in CCLm. A high positive correlation was observed between the percentage of IFN-γ-producing CD4+ T cells and the released IFN-γ. We showed that the LaPSA-38S protein was able to induce a mixed Th1 and Th2/Treg cytokine response in individuals with immunity to L. major or L. infantum infection indicating that it may be exploited as a vaccine candidate. We also showed, to our knowledge for the first time, the capacity of Leishmania PSA protein to induce granzyme B production in humans with immunity to L. major and L. infantum infection. |
| format |
article |
| author |
Rym Chamakh-Ayari Rachel Bras-Gonçalves Narges Bahi-Jaber Elodie Petitdidier Wafa Markikou-Ouni Karim Aoun Javier Moreno Eugenia Carrillo Poonam Salotra Himanshu Kaushal Narender Singh Negi Jorge Arevalo Francesca Falconi-Agapito Angela Privat Maria Cruz Julie Pagniez Gérard-Marie Papierok Faten Bel Haj Rhouma Pilar Torres Jean-Loup Lemesre Mehdi Chenik Amel Meddeb-Garnaoui |
| author_facet |
Rym Chamakh-Ayari Rachel Bras-Gonçalves Narges Bahi-Jaber Elodie Petitdidier Wafa Markikou-Ouni Karim Aoun Javier Moreno Eugenia Carrillo Poonam Salotra Himanshu Kaushal Narender Singh Negi Jorge Arevalo Francesca Falconi-Agapito Angela Privat Maria Cruz Julie Pagniez Gérard-Marie Papierok Faten Bel Haj Rhouma Pilar Torres Jean-Loup Lemesre Mehdi Chenik Amel Meddeb-Garnaoui |
| author_sort |
Rym Chamakh-Ayari |
| title |
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. |
| title_short |
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. |
| title_full |
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. |
| title_fullStr |
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. |
| title_full_unstemmed |
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. |
| title_sort |
in vitro evaluation of a soluble leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/43367cf9df764d0c9cb36074fe25178c |
| work_keys_str_mv |
AT rymchamakhayari invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT rachelbrasgoncalves invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT nargesbahijaber invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT elodiepetitdidier invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT wafamarkikououni invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT karimaoun invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT javiermoreno invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT eugeniacarrillo invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT poonamsalotra invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT himanshukaushal invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT narendersinghnegi invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT jorgearevalo invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT francescafalconiagapito invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT angelaprivat invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT mariacruz invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT juliepagniez invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT gerardmariepapierok invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT fatenbelhajrhouma invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT pilartorres invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT jeanlouplemesre invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT mehdichenik invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT amelmeddebgarnaoui invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis |
| _version_ |
1718421855836045312 |